D. Abhyankar

发表

Pharmacokinetics of fixed-dose combination of tenofovir disoproxil fumarate, lamivudine, and efavirenz: results of a randomized, crossover, bioequivalence study

D. Abhyankar, Ashish Shedage, M. Gole, 2017, International journal of STD & AIDS.

The study of c-Src kinase and pStat3 protein expression in retinoblastoma.

A. Mohan, K. Mallikarjuna, S. Krishnakumar, 2006, Experimental eye research.

HLA class II antigen expression in uveal melanoma: correlation with clinicopathological features.

M. Shanmugam, J. Biswas, S. Krishnakumar, 2003, Experimental eye research.

Bioequivalence Study of Rivastigmine 6 mg Capsules (Single Dose) in Healthy Volunteers

D. Abhyankar, Ashish Shedage, M. Gole, 2017, American journal of Alzheimer's disease and other dementias.

Loss of antigen-processing molecules in primary orbital melanoma

J. Biswas, S. Krishnakumar, D. Abhyankar, 2003, Orbit.

Human Leukocyte Class I Antigen and β2-Microglobulin Expression in Conjunctival Dysplasia, Carcinoma In Situ, and Squamous Cell Carcinoma

J. Biswas, S. Krishnakumar, D. Abhyankar, 2005, Cornea.

Major histocompatibility antigens and antigen-processing molecules in uveal melanoma.

M. Shanmugam, J. Biswas, S. Krishnakumar, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

HLA expression in choroidal melanomas: Correlation with clinicopathological features

M. Shanmugam, J. Biswas, S. Krishnakumar, 2004, Current eye research.

Major histocompatibility antigens and antigen‐processing molecules in retinoblastoma

M. Shanmugam, L. Gopal, J. Biswas, 2004, Cancer.

Gut Microbiota and Response to Immunotherapeutic Drugs in Oncology: More Questions Than Answers

K. Mckee, D. Abhyankar, Pavle Vukojevic, 2020, Clinical Medicine Insights. Oncology.

Transporter associated protein expression in uveal melanoma

S. Krishnakumar, J. Biswas, D. Abhyankar, 2004, British Journal of Ophthalmology.

Expression of HLA class I, ß2-microglobulin and HLA class II antigens in primary orbital melanoma

J. Biswas, S. Krishnakumar, D. Abhyankar, 2003, Orbit.

The Observed Correlation between in vivo Clinical Pharmacokinetic Parameters and in vitro Potency of VEGFR-2 Inhibitors

N. Srinivas, D. Abhyankar, B. Benjamin, 2012, Arzneimittelforschung/Drug Research.

HLA class II antigen expression in conjunctival precancerous lesions and squamous cell carcinomas

J. Biswas, S. Krishnakumar, D. Abhyankar, 2003, Current eye research.

Phase I trial of the CDK 4/6 inhibitor, P1446A-05 (voruciclib) in combination with the BRAF inhibitor (BRAFi), vemurafenib in advanced, BRAF-mutant melanoma.

Alison Martin, A. Daud, A. Algazi, 2015 .

Bioequivalence study of cyclizine hydrochloride 50 mg tablets in healthy volunteers: a randomized, open-label, single-dose study.

D. Abhyankar, Ashish Shedage, M. Gole, 2016, Therapeutic delivery.

Ipilimumab: A tale of twists and turns

D. Abhyankar, 2018, South Asian Journal of Cancer.